A record year for biotech investments in UK, a year after the Brexit
by Giuliana Miglierini One year after the Brexit, the UK’s economic landscape is far from being suffering for…
A golden era for UK’s life sciences and a new Code of practice for its pharmaceutical industry
by Giuliana Miglierini Less than a year has gone since the Brexit, and the UK innovation landscape is…